arginine and Bladder Cancer

arginine has been researched along with Bladder Cancer in 44 studies

Research

Studies (44)

TimeframeStudies, this research(%)All Research%
pre-199027 (61.36)18.7374
1990's4 (9.09)18.2507
2000's2 (4.55)29.6817
2010's5 (11.36)24.3611
2020's6 (13.64)2.80

Authors

AuthorsStudies
Alsyouf, M; Daneshmand, S; Djaladat, H1
Chen, S; Chen, X; Chen, Y; Cheng, L; Dong, W; Huang, J; Huang, M; Li, W; Lin, T; Peng, S; Su, Q; Wu, J; Xie, R; Yao, K; Zhang, Q; Zhou, Q1
Fan, W; Lai, WF; Liu, Y; Liu, Z; Ma, M; Qi, X; Qin, X; Sun, L; Wang, H; Wang, S; Zhang, D; Zhang, H; Zhang, P; Zheng, B1
Kong, C; Liu, S; Liu, X; Liu, Z; Piao, C; Yin, L; Zhang, Z1
Cheng, PN; Ho, JC; Ke, C; Li, W; Liu, Y; Wang, D; Xu, S; Zhang, P; Zhao, Z1
Hannah, P; Khaleel, S; Konety, B; Regmi, S; Sathianathen, N; Watarai, B; Weight, C1
Davies, BJ; Gingrich, JR; Hrebinko, RL; Jacobs, BL; Lyon, TD; McBride, D; Tarin, TV; Turner I I, RM; Wang, L1
Bechtel, MD; Carlson, SE; Chalise, P; Hamilton-Reeves, JM; Hand, LK; Holzbeierlein, JM; Hull, H; Lee, EK; Mirza, M; Smelser, W; Stanley, A; Wyre, H; Yankee, TM1
Field, HI; Hamamoto, R; Hayami, S; Kelly, JD; Maehara, Y; Nakamura, Y; Neal, DE; Ponder, BA; Toyokawa, G; Tsunoda, T; Unoki, M; Yoshimatsu, M1
Afroze, D; Khan, NP; Pandith, AA; Rasool, R; Shah, ZA; Siddiqi, M; Wani, S; Yousuf, A1
Xia, YC; Xiao, P; Yuan, XK; Zhao, XK; Zhu, X1
Closs, EI; Habermeier, A; Martiné, U; Plies, L; Reining, M; Simon, A1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW1
Andreesen, R; Konur, A; Krause, SW; Kreutz, M; Rehli, M1
Adolfsson, J; Jansson, OT; Kratz, G; Morcos, E; Wiklund, NP1
Blanck, G; Eason, DD; Shepherd, AT1
Płuzańska, A; Robak, T1
Dalesio, O; De Pauw, M; Denis, L; Robinson, M; Schulman, CC; Smith, P; Sylvester, R; Viggiano, G2
Lum, BL1
Ingargiola, GB; Pavone-Macaluso, M; Tripi, M1
Dalesio, O; Glashan, R; Green, DF; Newling, D; Robinson, MR; Smith, PH1
Lum, BL; Torti, FM1
de Pauw, M; Fosså, SD; Mulder, JH; Stoter, G; van Oosterom, AT1
Soloway, MS1
Baumgartner, G1
Hofmann, W; Langkopf, B1
Abbou, C; Auvert, J; Botto, H; Garcia-Giralt, E; Hannoun, M; Jouve, M; Lachand, AT; Morin, P; Palangie, T; Pouillart, P1
El-Morsi, B; El-Sebai, IT; Gad-el-Mawla, NM; Hamza, MR; Khafagy, M; Mansour, MA; Muggia, FM; Sherif, M1
Sherif, M1
Pavone-Macaluso, M1
De Pauw, M; Denis, L; Lachand, A; Pavone-Macaluso, M; Robinson, M; Schulman, C; Smith, P; Staquet, M; Sylvester, R1
Henney, JE; Muggia, FM; Rozencweig, M; Von Hoff, DD1
Caramia, G; Messana, V; Pavone-Macaluso, M; Rizzo, FP1
Kenis, Y; Rozencweig, M; Schulman, CC; Staquet, M; Sylvester, R1
Mechl, Z; Rovný, F; Sopková, B1
Ingargiola, GB; Pavone-Macaluso, M; Serretta, V1
Carbone, A; Carmignani, G; Dal Bo, V; Francini, M; Lo Re, G; Magri, MD; Merlo, A; Morassut, S; Talamini, R; Veronesi, A1
Alexander, RB; Coffey, DS; Isaacs, JT1
Carbone, A; Dal Bo, V; Francini, M; Monfardini, S; Veronesi, A1
Aso, Y; Fukushima, M; Matsuura, O; Naide, Y; Ohshima, S; Ono, Y; Ota, K; Suzuki, K; Tajima, A; Ushiyama, T1
Berenberg, J; Blumenstein, BA; Bukowski, RM; Johnson, K; O'Bryan, RM; Oishi, N; Quagliana, J; Rivkin, SE; Saiers, JH; Stephens, RL1
Frommhold, H; Jakse, G; zur Nedden, D1

Reviews

6 review(s) available for arginine and Bladder Cancer

ArticleYear
Intravesical chemotherapy of superficial bladder cancer.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1983, Volume: 85

    Topics: Absorption; Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma in Situ; Doxorubicin; Endoscopy; Ethoglucid; Humans; Hydrogen-Ion Concentration; Mitomycin; Mitomycins; Molecular Weight; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1983
The biology and treatment of superficial bladder cancer.
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5

    Topics: Adenocarcinoma; Aged; Antineoplastic Agents; BCG Vaccine; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Combined Modality Therapy; Cystoscopy; Doxorubicin; Ethoglucid; Female; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms

1984
Rationale for intensive intravesical chemotherapy for superficial bladder cancer.
    The Journal of urology, 1980, Volume: 123, Issue:4

    Topics: Animals; Antineoplastic Agents; BCG Vaccine; Carcinoma, Transitional Cell; Doxorubicin; Humans; Mitomycins; Neoplasm Recurrence, Local; Neoplasm Seeding; Neoplasms, Experimental; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1980
[Progress in the internist treatment of bladder tumors].
    Wiener medizinische Wochenschrift (1946), 1982, Jul-31, Volume: 132, Issue:13-14

    Topics: Antineoplastic Agents; BCG Vaccine; Cisplatin; Doxorubicin; Ethoglucid; Humans; Leucovorin; Methotrexate; Mitomycins; Neoplasm Metastasis; Neoplasm Recurrence, Local; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1982
VM 26 and VP 16-213: a comparative analysis.
    Cancer, 1977, Volume: 40, Issue:1

    Topics: Animals; Brain Neoplasms; Drug Evaluation; Etoposide; Humans; Kinetics; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms, Experimental; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1977
The role of epipodophyllotoxin derivatives in bladder cancer.
    Seminars in oncology, 1992, Volume: 19, Issue:2 Suppl 6

    Topics: Combined Modality Therapy; Etoposide; Humans; Remission Induction; Teniposide; Urinary Bladder Neoplasms

1992

Trials

10 trial(s) available for arginine and Bladder Cancer

ArticleYear
Perioperative Immunonutrition Modulates Inflammatory Response after Radical Cystectomy: Results of a Pilot Randomized Controlled Clinical Trial.
    The Journal of urology, 2018, Volume: 200, Issue:2

    Topics: Adjuvants, Immunologic; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Arginine; Cystectomy; Dietary Supplements; Humans; Lymphocyte Count; Male; Neoadjuvant Therapy; Nutritional Status; Pilot Projects; Postoperative Complications; Preoperative Care; Prospective Studies; Th1 Cells; Th2 Cells; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms

2018
[New antineoplastic drugs of the podophyllotoxin derivative group].
    Polski tygodnik lekarski (Warsaw, Poland : 1960), 1983, Jan-03, Volume: 38, Issue:1

    Topics: Adult; Child; Clinical Trials as Topic; Etoposide; Female; Humans; Leukemia; Lung Neoplasms; Lymphoma; Neoplasms; Ovarian Neoplasms; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1983
Prognostic factors in superficial bladder tumors. A study of the European Organization for Research on Treatment of Cancer: Genitourinary Tract Cancer Cooperative Group.
    The Journal of urology, 1983, Volume: 129, Issue:4

    Topics: Humans; Neoplasm Recurrence, Local; Prognosis; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1983
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11 Suppl

    Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Doxorubicin; Humans; Multi-Institutional Systems; Neoplasm Recurrence, Local; Prognosis; Pyridoxine; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1983
Prophylactic chemotherapy of superficial transitional cell bladder carcinoma: an EORTC randomized trial comparing thiotepa, an epipodophyllotoxin (VM26) and TUR alone.
    European urology, 1982, Volume: 8, Issue:4

    Topics: Carcinoma, Transitional Cell; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1982
Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.
    Cancer treatment reports, 1978, Volume: 62, Issue:7

    Topics: Adolescent; Adult; Aged; Altretamine; Carcinoma; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug Evaluation; Female; Humans; Male; Middle Aged; Podophyllotoxin; Schistosomiasis; Teniposide; Triazines; Urinary Bladder Diseases; Urinary Bladder Neoplasms

1978
A comprehensive protocol for management of cancer of the bilharzial bladder.
    Urological research, 1978, Volume: 6, Issue:4

    Topics: Altretamine; Humans; Schistosomiasis; Teniposide; Urinary Bladder Diseases; Urinary Bladder Neoplasms

1978
Adjuvant therapy of T1 bladder carcinoma: preliminary results of an EORTC randomized study.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1978, Volume: 68

    Topics: Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Pathology; Podophyllotoxin; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1978
Preliminary evaluation of VM-26: a new epipodophyllotoxin derivative, in the treatment of urogenital tumours.
    European urology, 1975, Volume: 1, Issue:1

    Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Agents; Carcinoma, Papillary; Chemotherapy, Cancer, Regional Perfusion; Clinical Trials as Topic; Drug Evaluation; Humans; Infusions, Parenteral; Leiomyosarcoma; Male; Mitosis; Neoplasm Metastasis; Podophyllotoxin; Prostatic Neoplasms; Teniposide; Teratoma; Testicular Neoplasms; Therapeutic Irrigation; Urinary Bladder Neoplasms

1975
EORTC randomized trial for the adjuvant therapy of T1 bladder carcinoma.
    European urology, 1976, Volume: 2, Issue:6

    Topics: Carcinoma, Papillary; Clinical Trials as Topic; Follow-Up Studies; Humans; Neoplasm Recurrence, Local; Podophyllotoxin; Postoperative Care; Remission, Spontaneous; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms

1976

Other Studies

28 other study(ies) available for arginine and Bladder Cancer

ArticleYear
An emerging role for immuno-nutrition in patients undergoing radical cystectomy.
    Nature reviews. Urology, 2022, Volume: 19, Issue:1

    Topics: Arginine; Cystectomy; Humans; Immune System; Nutrition Therapy; Preoperative Period; Urinary Bladder Neoplasms

2022
HSF1 facilitates the multistep process of lymphatic metastasis in bladder cancer via a novel PRMT5-WDR5-dependent transcriptional program.
    Cancer communications (London, England), 2022, Volume: 42, Issue:5

    Topics: Arginine; Cell Line, Tumor; Heat Shock Transcription Factors; Histones; Humans; Intracellular Signaling Peptides and Proteins; Lymphatic Metastasis; Protein-Arginine N-Methyltransferases; Urinary Bladder Neoplasms

2022
Combined Self-Assembled Hendeca-Arginine Nanocarriers for Effective Targeted Gene Delivery to Bladder Cancer.
    International journal of nanomedicine, 2022, Volume: 17

    Topics: Administration, Intravesical; Animals; Arginine; Clathrin; DNA; Genetic Therapy; Glycosaminoglycans; Humans; Mice; Nitrogen; Peptides; Phosphates; Urinary Bladder Neoplasms

2022
Flavokawain A is a natural inhibitor of PRMT5 in bladder cancer.
    Journal of experimental & clinical cancer research : CR, 2022, Oct-05, Volume: 41, Issue:1

    Topics: Arginine; Biological Products; Chalcone; Enzyme Inhibitors; Histones; Humans; Molecular Docking Simulation; Protein-Arginine N-Methyltransferases; Urinary Bladder Neoplasms

2022
Pegylated Recombinant Human Arginase 1 Induces Autophagy and Apoptosis via the ROS-Activated AKT/mTOR Pathway in Bladder Cancer Cells.
    Oxidative medicine and cellular longevity, 2021, Volume: 2021

    Topics: Animals; Apoptosis; Arginase; Arginine; Autophagy; Cell Line, Tumor; Female; Humans; Membrane Potential, Mitochondrial; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Neoplasm Proteins; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species; Recombinant Proteins; Signal Transduction; TOR Serine-Threonine Kinases; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2021
Impact of Preoperative Immunonutrition on Perioperative Outcomes following Cystectomy.
    The Journal of urology, 2021, Volume: 206, Issue:5

    Topics: Aged; Arginine; Cystectomy; Dietary Supplements; Female; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Postoperative Complications; Preoperative Care; Retrospective Studies; Treatment Outcome; Urinary Bladder; Urinary Bladder Neoplasms

2021
Preoperative immunonutrition prior to radical cystectomy: a pilot study.
    The Canadian journal of urology, 2017, Volume: 24, Issue:4

    Topics: Aged; Arginine; Cystectomy; Female; Humans; Male; Middle Aged; Pilot Projects; Postoperative Complications; Preoperative Care; Urinary Bladder Neoplasms

2017
Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers.
    International journal of cancer, 2011, Feb-01, Volume: 128, Issue:3

    Topics: Anthracenes; Arginine; Carcinoma, Non-Small-Cell Lung; Cell Division; Cell Line, Tumor; DNA Replication; Enzyme-Linked Immunosorbent Assay; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Neoplasms; Nuclear Proteins; Oligonucleotide Array Sequence Analysis; Propane; Protein-Arginine N-Methyltransferases; Repressor Proteins; RNA, Small Interfering; Urinary Bladder Neoplasms

2011
Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
    Cancer genetics and cytogenetics, 2010, Volume: 203, Issue:2

    Topics: Adult; Arginine; Female; Genes, p53; Genetic Predisposition to Disease; Genotype; Humans; India; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Proline; Risk Factors; Smoking; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms

2010
Increased circulating immunosuppressive CD14(+)HLA-DR(-/low) cells correlate with clinical cancer stage and pathological grade in patients with bladder carcinoma.
    The Journal of international medical research, 2011, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Arginase; Arginine; Case-Control Studies; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; HLA-DR Antigens; Humans; Interferon-gamma; Leukocytes, Mononuclear; Lipopolysaccharide Receptors; Lymphocyte Activation; Male; Middle Aged; Myeloid Cells; Neoplasm Staging; Phenotype; T-Lymphocytes; Transforming Growth Factor beta; Urinary Bladder; Urinary Bladder Neoplasms

2011
Role of neutral amino acid transport and protein breakdown for substrate supply of nitric oxide synthase in human endothelial cells.
    Circulation research, 2003, Oct-31, Volume: 93, Issue:9

    Topics: Amino Acid Transport Systems, Neutral; Amino Acids; Amino Acids, Neutral; Animals; Arginine; Biological Transport; Carcinoma; Cells, Cultured; Citrulline; Endothelium, Vascular; Glutamine; Humans; Intracellular Fluid; Membrane Transport Proteins; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Proteins; Rats; Substrate Specificity; Transfection; Umbilical Veins; Urinary Bladder Neoplasms

2003
Antitumor effect of ascorbic acid, lysine, proline, arginine, and green tea extract on bladder cancer cell line T-24.
    International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:4

    Topics: Antioxidants; Arginine; Ascorbic Acid; Biomarkers, Tumor; Camellia sinensis; Cell Line, Tumor; Cell Proliferation; Disease Progression; Female; Humans; In Vitro Techniques; Lysine; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Plant Extracts; Proline; Urinary Bladder Neoplasms

2006
Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide.
    Journal of immunology (Baltimore, Md. : 1950), 1996, Sep-01, Volume: 157, Issue:5

    Topics: Arginine; Carcinoma, Transitional Cell; Coculture Techniques; Drug Combinations; Humans; Interleukin-1; Kidney Medulla; Leucine; Macrophage Activation; Monocytes; Nitric Oxide; Nitric Oxide Synthase; Nitrites; omega-N-Methylarginine; Solubility; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1996
Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines.
    Urology, 1999, Volume: 53, Issue:6

    Topics: Arginine; Cell Division; Dose-Response Relationship, Drug; Humans; Nitric Oxide; Nitric Oxide Synthase; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1999
Interferon regulatory factor 1 tryptophan 11 to arginine point mutation abolishes DNA binding.
    Biochimica et biophysica acta, 1999, Jul-07, Volume: 1446, Issue:1-2

    Topics: Arginine; Carcinoma, Non-Small-Cell Lung; DNA-Binding Proteins; Electrophoresis; Humans; Interferon Regulatory Factor-1; Lung Neoplasms; Phosphoproteins; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Transcription Factors; Transcription, Genetic; Transfection; Tryptophan; Tumor Cells, Cultured; Urinary Bladder Neoplasms

1999
Does intravesical chemotherapy prevent invasive bladder cancer?
    The Journal of urology, 1984, Volume: 131, Issue:1

    Topics: Administration, Topical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Follow-Up Studies; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Random Allocation; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1984
Combination chemotherapy with cisplatin and VM-26 in advanced transitional cell carcinoma of the bladder.
    European journal of cancer & clinical oncology, 1984, Volume: 20, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Teniposide; Urinary Bladder Neoplasms

1984
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
    Zeitschrift fur Urologie und Nephrologie, 1982, Volume: 75, Issue:12

    Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms

1982
Combined chemotherapy in the management of metastatic bladder cancer.
    British journal of urology, 1981, Volume: 53, Issue:4

    Topics: Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Fluorouracil; Humans; Mitomycins; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1981
Single-drug chemotherapy of bladder cancer with adriamycin, VM-26 or bleomycin. A phase II multicentric, co-operative study.
    European urology, 1976, Volume: 2, Issue:3

    Topics: Bleomycin; Doxorubicin; Humans; Neoplasm Metastasis; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1976
Chemotherapy of bladder tumours.
    Urological research, 1978, Volume: 6, Issue:4

    Topics: Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Papillary; Humans; Neoplasm Metastasis; Papilloma; Recurrence; Teniposide; Thiotepa; Urinary Bladder Neoplasms

1978
VM 26 (4-demethyl-epipodophyllotoxin-beta-d-thenylidine glucoside) in the treatment of urinary bladder tumors.
    Neoplasma, 1977, Volume: 24, Issue:4

    Topics: Carcinoma, Papillary; Humans; Podophyllotoxin; Recurrence; Remission, Spontaneous; Teniposide; Time Factors; Urinary Bladder Neoplasms

1977
Presurgery chemotherapy (CT) in locally advanced bladder carcinoma: a feasible and possibly effective approach.
    Medical oncology and tumor pharmacotherapy, 1989, Volume: 6, Issue:2

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Prospective Studies; Remission Induction; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

1989
Tumor necrosis factor enhances the in vitro and in vivo efficacy of chemotherapeutic drugs targeted at DNA topoisomerase II in the treatment of murine bladder cancer.
    The Journal of urology, 1987, Volume: 138, Issue:2

    Topics: Animals; Antineoplastic Agents; Dactinomycin; DNA Topoisomerases, Type II; Doxorubicin; Etoposide; Female; Glycoproteins; Macrophage Activation; Mice; Recombinant Proteins; Teniposide; Tumor Necrosis Factor-alpha; Urinary Bladder Neoplasms

1987
Pre surgery chemotherapy in bladder cancer.
    Progress in clinical and biological research, 1988, Volume: 260

    Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Preoperative Care; Teniposide; Urinary Bladder Neoplasms

1988
[Use of VM-26 as a single agent in the treatment of transitional cell carcinoma of the urinary tract].
    Nihon Gan Chiryo Gakkai shi, 1988, May-20, Volume: 23, Issue:5

    Topics: Adult; Aged; Carcinoma, Transitional Cell; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Podophyllotoxin; Teniposide; Ureteral Neoplasms; Urinary Bladder Neoplasms

1988
Teniposide in metastatic renal and bladder cancer: a Southwest Oncology Group Study.
    Cancer treatment reports, 1987, Volume: 71, Issue:12

    Topics: Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Female; Humans; Kidney Neoplasms; Male; Podophyllotoxin; Teniposide; Urinary Bladder Neoplasms

1987
Combined radiation and chemotherapy for locally advanced transitional cell carcinoma of the urinary bladder.
    Cancer, 1985, Apr-15, Volume: 55, Issue:8

    Topics: Aged; Carcinoma, Transitional Cell; Cisplatin; Combined Modality Therapy; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Prospective Studies; Teniposide; Tomography, X-Ray Computed; Urinary Bladder Neoplasms

1985